FDA criticizes AbbVie for its handling of death complaints

The FDA reprimanded AbbVie in a recent report for not properly investigating death reports linked to three of its medications, including its blockbuster drug Humira.

Source: PharmaManufacturing.com - June 11, 2018 Category: Pharmaceuticals Source Type: news